Subscribe to Newsletter

February 2018 Issue of The Medicine Maker

Welcome to the February issue. Upfront covers an implantable neural device that can deliver drugs with great accuracy, and a study on the inclusion of women in clinical trials. David Harry explains why pharma companies will increasingly rely on software to keep all of their balls in the air in In My View. Our cover feature delves in to the deep waters of biopharmaceutical analysis with four analytical experts as your guide. In Business, we look at how Brexit could impact pharma supply chains, and in Best Practice Adrian Carter calls for pharma to embrace the crowdsourcing phenomenon. Finally, we Sit Down With Nigel Darby of GE Healthcare to discuss destroying saucepans, moving from research to industry, and the rise of biopharmaceuticals.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Business & Regulation Business Practice

Are You Ready?

| James Strachan

Brexit could cause chaos for fragile supply chains – especially if companies are unprepared.

Discovery & Development Drug Delivery

A Goal in MiNDS

| James Strachan

An implantable neural device can deliver drugs to the brain with pinpoint accuracy.

Manufacture Business Practice


| Roisin McGuigan

Bribery investigations, sitting out the Super Bowl, and achieving excellence online…

Business & Regulation Business Practice

What’s in a (Brand) Name?

| Roisin McGuigan

Do patients care about your brand? Not as much as they care about your outcomes.

Discovery & Development Clinical Trials

Cherchez la Femme?

| Roisin McGuigan

A review of FDA data suggests that women are now better represented in clinical trials.

Manufacture Business Practice

Innovation: Your Way

| Stephanie Vine

Register your vote in The Medicine Maker Innovation Awards!

Manufacture Bioprocessing - Single Use Systems

Trials of a Medicine Maker

Why embracing single use could help you hedge your bets…

Manufacture Vaccines

Dengue Vaccine 101

| Stephanie Vine

What sparked fears and prompted an anti-vax movement in the Philippines?

Manufacture Analytical Science

Think Fast, Screen Faster

| Roisin McGuigan

Ten thousand reactions per hour – or else? No problem!

Manufacture Business Practice

Software: The Best of Jugglers

| David Harty

Pharma companies will increasingly turn to software that can harness data in new ways.

Discovery & Development Formulation

The Next (Air)Wave of Inhalables

| David Lewis

For inhaler technology to evolve, questions about efficacy must be answered.

Manufacture Analytical Science

Deep Dive into Biopharmaceutical Analysis

| Stephanie Vine

We speak with four experts to gain a fresh perspective on biopharmaceutical characterization.

Business & Regulation Business Practice

Hold Me Closer, UK Pharma

| James Strachan

Pharma calls for close cooperation and clarity as soon as possible.

Business & Regulation Business Practice

A Problem Shared…

| Roisin McGuigan

It’s time for pharma to join the crowdsourcing revolution.

Business & Regulation Facilities

Fumigation: Choose Your Weapon!

| Andrew Ramage

Replacing a fumigation system? As a former site fumigation lead, here is how I would go about it.

Manufacture Business Practice

From Strength to Strength

| Roisin McGuigan

Sitting Down With… Nigel Darby, Advisor, GE Healthcare Life Sciences, Sweden.

Manufacture Technology and Equipment

Getting on the Fast Track: Manufacturing Training for Cell Therapies

| Trevor Smith

Looking to advance in the exciting area of cell therapy?

Manufacture Bioprocessing - Upstream & Downstream

The Continuous Way

| Sponsored by Pall Biotech

Are we entering a new era of continuous bioprocessing? Pall’s experts discuss the opportunities and challenges ahead.

Discovery & Development Business Practice

In Conversation with Tony van Bijleveld from Patheon part of Thermo Fisher Scientific at CPhI 2017

Here, James speaks with Tony van Bijleveld from Thermo Fischer Scientific (Patheon).

Discovery & Development Business Practice

In Conversation with Michel Lagarde from Patheon part of Thermo Fisher Scientific at CPhI 2017

Here, James speaks with Michel Lagarde from Thermo Fischer Scientific (Patheon).

Discovery & Development Business Practice

In Conversation with Christophe Le Ret of Umicore Precious Metals Chemistry at CPhI 2017

Here, James speaks with Christophe Le Ret from Umicore.

Other issues of 2018